X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Vanta Bioscience Ltd.
BSE CODE: 540729   |   NSE CODE: NA   |   ISIN CODE : INE695X01011   |   16-May-2024 Hrs IST
BSE NSE
Rs. 73.50
0 ( 0% )
 
Prev Close ( Rs.)
73.50
Open ( Rs.)
71.44
 
High ( Rs.)
73.50
Low ( Rs.)
71.44
 
Volume
1500
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Particulars Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Operational & Financial Ratios          
   Earnings Per Share (Rs)-6.71  0.12  0.75  1.55  1.10  
   CEPS(Rs)-4.73  2.21  2.73  3.43  2.23  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)31.28  38.01  37.88  37.14  35.24  
   Tax Rate(%)-0.67  43.78  22.27  24.07  36.79  
Margin Ratios          
   Core EBITDA Margin(%)-9.20  36.38  38.79  30.58  26.30  
   EBIT Margin(%)-21.28  24.10  26.53  22.93  22.42  
   Pre Tax Margin(%)-81.36  1.49  6.03  9.13  8.83  
   PAT Margin (%)-81.91  0.84  4.68  6.93  5.58  
   Cash Profit Margin (%)-57.73  14.92  17.15  15.35  11.31  
Performance Ratios          
   ROA(%)-8.30  0.16  1.07  2.45  2.06  
   ROE(%)-19.37  0.33  1.99  4.28  3.57  
   ROCE(%)-2.44  5.24  6.76  8.86  8.81  
   Asset Turnover(x)0.10  0.19  0.23  0.35  0.37  
   Sales/Fixed Asset(x)0.12  0.25  0.36  0.67  0.67  
   Working Capital/Sales(x)5.84  9.17  3.77  1.36  1.14  
Efficiency Ratios          
   Fixed Capital/Sales(x)8.20  3.97  2.81  1.50  1.50  
   Receivable days93.40  52.75  60.64  37.76  27.82  
   Inventory Days507.98  331.82  432.17  300.67  180.21  
   Payable days1023.32  565.86  213.02  146.72  85.06  
Valuation Parameters          
   PER(x)0.00  883.04  218.76  58.73  139.16  
   PCE(x)-12.16  49.72  59.76  26.51  68.73  
   Price/Book(x)1.84  2.89  4.30  2.45  4.34  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)11.99  9.63  12.24  5.21  9.06  
   EV/Core EBITDA(x)413.82  25.22  30.68  16.16  31.31  
   EV/EBIT(x)-56.32  39.96  45.09  22.09  39.30  
   EV/CE(x)1.20  1.78  2.59  1.71  2.87  
   M Cap / Sales7.02  7.42  10.48  4.19  7.99  
Growth Ratio          
   Net Sales Growth(%)-44.69  -4.74  -28.48  13.61  211.61  
   Core EBITDA Growth(%)-95.80  -8.83  -11.53  26.54  222.76  
   EBIT Growth(%)-148.84  -15.40  -17.70  16.16  444.87  
   PAT Growth(%)-5495.52  -83.31  -51.91  40.97  2441.91  
   EPS Growth(%)-5494.05  -83.30  -51.91  40.97  2209.03  
Financial Stability Ratios          
   Total Debt/Equity(x)1.30  0.87  0.72  0.60  0.60  
   Current Ratio(x)1.09  1.10  1.24  2.42  4.29  
   Quick Ratio(x)0.39  0.38  0.35  0.50  1.49  
   Interest Cover(x)-0.35  1.07  1.29  1.66  1.65  
   Total Debt/Mcap(x)0.71  0.30  0.17  0.25  0.14